YBYounes Boulaguiem

Younes Boulaguiem

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Younes Boulaguiem has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Fiducial Matching: Differentially Private Inference for Categorical Data

    by Ogonnaya Michael Romanus, Younes Boulaguiem, Roberto Molinari

    The task of statistical inference, which includes the building of confidence intervals and tests for parameters and effects of interest to a researcher, is still an open area of investigation in a differentially private (DP) setting. Indeed, in addition to the randomness due to data sampling, DP delivers another source of randomness consisting of the noise added to protect an individual's data from being disclosed to a potential attacker. As a result of this convolution of noises, in many cases it is too complicated to determine the stochastic behavior of the statistics and parameters resulting from a DP procedure. In this work, we contribute to this line of investigation by employing a simulation-based matching approach, solved through tools from the fiducial framework, which aims to replicate the data generation pipeline (including the DP step) and retrieve an approximate distribution of the estimates resulting from this pipeline. For this purpose, we focus on the analysis of categorical (nominal) data that is common in national surveys, for which sensitivity is naturally defined, and on additive privacy mechanisms. We prove the validity of the proposed approach in terms of coverage and highlight its good computational and statistical performance for different inferential tasks in simulated and applied data settings.

  • Open Access

    Multivariate Adjustments for Average Equivalence Testing

    by Younes Boulaguiem, Luca Insolia, Maria‐Pia Victoria‐Feser, Dominique‐Laurent Couturier, Stéphane Guerrier

    Multivariate (average) equivalence testing is widely used to assess whether the means of two conditions of interest are “equivalent” for different outcomes simultaneously. In pharmacological research for example, many regulatory agencies require the generic product and its brand‐name counterpart to have equivalent means both for the AUC and C max pharmacokinetics parameters. The multivariate Two One‐Sided Tests (TOST) procedure is typically used in this context by checking if, outcome by outcome, the marginal confidence intervals for the difference in means between the two conditions of interest lie within predefined lower and upper equivalence limits. This procedure, already known to be conservative in the univariate case, leads to a rapid power loss when the number of outcomes increases, especially when one or more outcome variances are relatively large. In this work, we propose a finite‐sample adjustment for this procedure, the multivariate ‐TOST, that consists in a correction of , the significance level, taking the (arbitrary) dependence between the outcomes of interest into account and making it uniformly more powerful than the conventional multivariate TOST. We present an iterative algorithm allowing to efficiently define , the corrected significance level, a task that proves challenging in the multivariate setting due to the inter‐relationship between and the sets of values belonging to the null hypothesis space and defining the test size. We study the operating characteristics of the multivariate ‐TOST both theoretically and via an extensive simulation study considering cases relevant for real‐world analyses—that is, relatively small sample sizes, unknown and possibly heterogeneous variances as well as different correlation structures—and show the superior finite‐sample properties of the multivariate ‐TOST compared to its conventional counterpart. We finally re‐visit a case study on ticlopidine hydrochloride and compare both methods when simultaneously assessing bioequivalence for multiple pharmacokinetic parameters.


  • Open Access

    Patient-Perceived Impact of the COVID-19 Pandemic on Medication Adherence and Access to Care for Long-Term Diseases: A Cross-Sectional Online Survey

    by Beatriz Santos, Younes Boulaguiem, Helene Baysson, Nick Pullen, Idris Guessous, Stephane Guerrier, Silvia Stringhini, Marie P. Schneider

    The COVID-19 pandemic has been associated with lifestyle changes, reduced access to care and potential impacts on medication self-management. Our main objectives are to evaluate the impact of the pandemic on patient adherence and access to care and long-term medications and determine its association with sociodemographic and clinical factors. This study is part of the Specchio-COVID-19 longitudinal cohort study in Geneva, Switzerland, conducted through an online questionnaire. Among the 982 participants (median age: 56; 61% female), 827 took long-term medications. There were 76 reported changes in medication dosages, of which 24 (31%) were without a physician’s recommendation, and 51 delays in initiation or premature medication interruptions, of which 24 (47%) were without a physician’s recommendation. Only 1% (9/827) of participants faced medication access issues. Participants taking a respiratory medication had a four-times greater odds of reporting more regular medication (OR = 4.27; CI 95%: 2.11–8.63) intake, whereas each year increase in age was significantly associated with 6% fewer relative risks of discontinuation (OR = 0.94; CI 95%: 0.91–0.97) and 3% fewer relative risks of changes in medication dosage (OR = 0.97; CI 95%: 0.95–1.00). Despite the limited impact of the pandemic on adherence and access to medications, our results emphasize the need for understanding patient challenges when self-managing their long-term medication, notably during public health crises.


  • Open Access

    Finite sample corrections for average equivalence testing

    by Younes Boulaguiem, Julie Quartier, Maria Lapteva, Yogeshvar N. Kalia, Maria‐Pia Victoria‐Feser, Stéphane Guerrier, Dominique‐Laurent Couturier

    Average (bio)equivalence tests are used to assess if a parameter, like the mean difference in treatment response between two conditions for example, lies within a given equivalence interval, hence allowing to conclude that the conditions have “equivalent” means. The two one‐sided tests (TOST) procedure, consisting in testing whether the target parameter is respectively significantly greater and lower than some pre‐defined lower and upper equivalence limits, is typically used in this context, usually by checking whether the confidence interval for the target parameter lies within these limits. This intuitive and visual procedure is however known to be conservative, especially in the case of highly variable drugs, where it shows a rapid power loss, often reaching zero, hence making it impossible to conclude for equivalence when it is actually true. Here, we propose a finite sample correction of the TOST procedure, the ‐TOST, which consists in a correction of the significance level of the TOST allowing to guarantee a test size (or type‐I error rate) of . This new procedure essentially corresponds to a finite sample and variability correction of the TOST procedure. We show that this procedure is uniformly more powerful than the TOST, easy to compute, and that its operating characteristics outperform the ones of its competitors. A case study about econazole nitrate deposition in porcine skin is used to illustrate the benefits of the proposed method and its advantages compared to other available procedures.


  • Open Access

    Influence of Molecular Structure and Physicochemical Properties of Immunosuppressive Drugs on Micelle Formulation Characteristics and Cutaneous Delivery

    by Julie Quartier, Maria Lapteva, Younes Boulaguiem, Stéphane Guerrier, Yogeshvar N. Kalia

    The aim of this study was to investigate whether subtle differences in molecular properties affected polymeric micelle characteristics and their ability to deliver poorly water-soluble drugs into the skin. D-α-tocopherol-polyethylene glycol 1000 was used to prepare micelles containing ascomycin-derived immunosuppressants—sirolimus (SIR), pimecrolimus (PIM) and tacrolimus (TAC)—which have similar structures and physicochemical properties and have dermatological applications. Micelle formulations were prepared by thin-film hydration and extensively characterized. Cutaneous delivery and biodistribution were determined and compared. Sub-10 nm micelles were obtained for the three immunosuppressants with incorporation efficiencies >85%. However, differences were observed for drug loading, stability (at the highest concentration), and their in vitro release kinetics. These were attributed to differences in drug aqueous solubility and lipophilicity. Differences between the cutaneous biodistribution profiles and drug deposition in the different skin compartments pointed to the impact of differences in thermodynamic activity. Therefore, despite their structural similarities, SIR, TAC and PIM did not demonstrate the same behaviour either in the micelles or when applied to the skin. These outcomes indicate that polymeric micelles should be optimized even for closely related drug molecules and support the hypothesis that drugs are released from micelles prior to skin penetration.


  • Open Access

    Finite Sample Corrections for Average Equivalence Testing

    by Younes Boulaguiem, Julie Quartier, Maria Lapteva, Yogeshvar N Kalia, Maria-Pia Victoria-Feser, Stéphane Guerrier, Dominique-Laurent Couturier

    A bstract: Average (bio)equivalence tests are used to assess if a parameter, like the mean difference in treatment response between two conditions for example, lies within a given equivalence interval, hence allowing to conclude that the conditions have ‘equivalent’ means. The Two One-Sided Tests (TOST) procedure, consisting in testing whether the target parameter is respectively significantly greater and lower than some pre-defined lower and upper equivalence limits, is typically used in this context, usually by checking whether the confidence interval for the target parameter lies within these limits. This intuitive and visual procedure is however known to be conservative, especially in the case of highly variable drugs, where it shows a rapid power loss, often reaching zero, hence making it impossible to conclude for equivalence when it is actually true. Here, we propose a finite sample correction of the TOST procedure, the α -TOST, which consists in a correction of the significance level of the TOST allowing to guarantee a test size (or type-I error rate) of α . This new procedure essentially corresponds to a finite sample and variability correction of the TOST procedure. We show that this procedure is uniformly more powerful than the TOST, easy to compute, and that its operating characteristics outperform the ones of its competitors. A case study about econazole nitrate deposition in porcine skin is used to illustrate the benefits of the proposed method and its advantages compared to other available procedures.


  • Open Access

    Faultlines within Sectors in Partnership Executive Boards

    by Moira V. Faul, Younes Boulaguiem

    The partnership model is ubiquitous in sustainability. Much of the partnership debate in research (and in policy and practice) revolves around differentiating between the public, private, and voluntary sectors from which partners are drawn. Differences between these sectors are assumed to affect the relations between them, and therefore the effectiveness of partnerships. Yet, differences beneath the surface of these categories are rarely examined. In this chapter we argue that the partnership debate's focus on sectoral factions disregards other aspects of diversity and their potential to affect partner relations and partnership effectiveness. “Diversity” signifies the extent to which members of a group are similar or dissimilar, and can be examined across multiple characteristics. These multiple dimensions of diversity provide some of the micro-foundations for relations between partners, a critical pathway to partnership effectiveness according to this volume's analytical framework (Chapter 1).

  • Open Access

    Modeling and simulating spatial extremes by combining extreme value theory with generative adversarial networks

    by Younes Boulaguiem, Jakob Zscheischler, Edoardo Vignotto, Karin van der Wiel, Sebastian Engelke

    Modeling dependencies between climate extremes is important for climate risk assessment, for instance when allocating emergency management funds. In statistics, multivariate extreme value theory is often used to model spatial extremes. However, most commonly used approaches require strong assumptions and are either too simplistic or over-parameterized. From a machine learning perspective, generative adversarial networks (GANs) are a powerful tool to model dependencies in high-dimensional spaces. Yet in the standard setting, GANs do not well represent dependencies in the extremes. Here we combine GANs with extreme value theory (evtGAN) to model spatial dependencies in summer maxima of temperature and winter maxima in precipitation over a large part of western Europe. We use data from a stationary 2000-year climate model simulation to validate the approach and explore its sensitivity to small sample sizes. Our results show that evtGAN outperforms classical GANs and standard statistical approaches to model spatial extremes. Already with about 50 years of data, which corresponds to commonly available climate records, we obtain reasonably good performance. In general, dependencies between temperature extremes are better captured than dependencies between precipitation extremes due to the high spatial coherence in temperature fields. Our approach can be applied to other climate variables and can be used to emulate climate models when running very long simulations to determine dependencies in the extremes is deemed infeasible.


  • Open Access

    Modelling and simulating spatial extremes by combining extreme value theory with generative adversarial networks

    by Younes Boulaguiem, Jakob Zscheischler, Edoardo Vignotto, Karin van der Wiel, Sebastian Engelke

    Modelling dependencies between climate extremes is important for climate risk assessment, for instance when allocating emergency management funds. In statistics, multivariate extreme value theory is often used to model spatial extremes. However, most commonly used approaches require strong assumptions and are either too simplistic or over-parameterized. From a machine learning perspective, Generative Adversarial Networks (GANs) are a powerful tool to model dependencies in high-dimensional spaces. Yet in the standard setting, GANs do not well represent dependencies in the extremes. Here we combine GANs with extreme value theory (evtGAN) to model spatial dependencies in summer maxima of temperature and winter maxima in precipitation over a large part of western Europe. We use data from a stationary 2000-year climate model simulation to validate the approach and explore its sensitivity to small sample sizes. Our results show that evtGAN outperforms classical GANs and standard statistical approaches to model spatial extremes. Already with about 50 years of data, which corresponds to commonly available climate records, we obtain reasonably good performance. In general, dependencies between temperature extremes are better captured than dependencies between precipitation extremes due to the high spatial coherence in temperature fields. Our approach can be applied to other climate variables and can be used to emulate climate models when running very long simulations to determine dependencies in the extremes is deemed infeasible.